Express report: pharmaceutical prime vendor (PPV)FY2026 june

Ended Awarded Last action

Contract number
36C24026K1009
Awardee
Awarding agency
Obligated
$1,191,973,258

Award facts

Contract value 100% obligated
$1,191,973,257.74 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Irving, TX 75039, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Defense issued a delivery order to McKesson Corporation on June 1, 2026, with a ceiling value of $1.19 billion under the Pharmaceutical Prime Vendor (PPV) program for FY2026.

McKesson, headquartered in Irving, Texas, is a major healthcare services and pharmaceutical distribution company providing comprehensive pharmaceutical distribution and medical supply chain management to federal agencies. The order is priced on a firm fixed price basis with an ultimate completion date of June 30, 2026. Place of performance is Irving, TX. The delivery order carries no set-aside designation.

Quick answers

Who was awarded contract 36C24026K1009?

36C24026K1009 was awarded to Mckesson Corporation by Headquarters (Department of Veterans Affairs) on June 1, 2026.

How much is contract 36C24026K1009 worth?

The government has obligated $1,191,973,258 on 36C24026K1009.

Is contract 36C24026K1009 an order under another contract?

Yes. 36C24026K1009 is a delivery order under 36W79720D0001, an indefinite delivery contract.

Was contract 36C24026K1009 competed?

The extent of competition for 36C24026K1009 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award